Affiliation:
1. Department of Geriatric Endocrinology, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, Jiangsu Province, China
2. Department of Endocrinology, Zhongda Hospital, Southeast University, Nanjing, Jiangsu Province, China.
Abstract
Rationale:
17α-Hydroxylase/17, 20-lyase deficiency (17OHD) is a recessively inherited autosomal disease caused by CYP17A1 gene mutations. It is characterized by failure to synthesize cortisol, adrenal androgens and gonadal steroids. However, it is rare in clinic combining with type 2 diabetes mellitus (T2DM).
Patient concerns:
A 21-year-old woman was transferred to an endocrinology clinic because of paroxysmal paralysis. In addition, she presented with hypertension, primary amenorrhea and lack of pubertal development. Blood evaluation revealed hypokalemia, and a low cortisol level with an increased adrenocorticotropic hormone concentration. The renin activity and testosterone and estrogen levels were suppressed, and the gonadotropin levels were high. CT scan showed bilateral adrenal hyperplasia. Besides, this patient had hyperglycemia, hyperinsulinism and negative diabetes type 1 related antibodies. A homozygous mutation c. 985 to 987delinsAA in exon 6 was found in the patient which caused the missense mutation (p.Y329fs).
Diagnoses:
17α-hydroxylase/17, 20-lyase deficiency combined with T2DM was considered.
Interventions:
The patient received dexamethasone, estradiol valerate, metformin, amlodipine besylate and D3 calcium carbonate tablets. The doses of dexamethasone was changed according to her blood potassium levels.
Outcomes:
After treatment, the blood pressure, blood potassium and blood glucose returned to normal range. Besides, she had restored her menstrual cycle.
Lessons:
For patients with hypertension, hypokalemia and lack of pubertal development, the possibility of 17OHD should be considered. The subsequent treatment would be challenging in patients with combined 17OHD and T2DM, considering the potential contribution of glucocorticoids to diabetic balance and osteoporosis.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference30 articles.
1. Congenital adrenal hyperplasia-current insights in pathophysiology, diagnostics, and management.;Claahsen-van der Grinten;Endocr Rev,2022
2. The syndrome of 17,20 lyase deficiency.;Miller;J Clin Endocrinol Metab,2012
3. A review of the literature on common CYP17A1 mutations in adults with 17-hydroxylase/17,20-lyase deficiency, a case series of such mutations among Koreans and functional characteristics of a novel mutation.;Kim;Metabolism,2014
4. A novel compound heterozygous CYP17A1 variant causes 17alpha-hydroxylase/17, 20-lyase deficiency.;Chen;Front Genet,2019
5. A case of 17 alpha-hydroxylase deficiency.;Kim;Clin Exp Reprod Med,2015